The non GAAP measures are presented in this press release as the Company's management believe that they will provide investors with a means of evaluating, and an understanding of how Shire's management evaluates, the Company's performance and results on a comparable basis that is not otherwise apparent on a US GAAP basis, since many one-time, infrequent or non-cash items that the Company's management believe are not indicative of the core performance of the business may not be excluded when preparing financial measures under US GAAP.
These non GAAP measures should not be considered in isolation from, as substitutes for, or superior to financial measures prepared in accordance with US GAAP.
Dial in details for the live conference call for investors 14:00
UK dial in: 0800-953-0934
US dial in: +1-866-224-2843
International dial in: +44-1452-569-102
Password/Conf ID: 34394878#
Click here for the webcast http://www.shire.com/shire/InvestorRelations/showevent.jsp?tn=2&m1=33&m2= &event=65
(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)
The following are trademarks of Shire or companies within the Shire
Group which are the subject of trademark registrations in certain
ADDERALL XR(R) (mixed salts of a single-entity amphetamine)
ADDERALL(R) (mixed salts of a single-entity amphetamine)
CALCICHEW(R) range (calcium carbonate with or without vitamin D3)
|SOURCE Shire plc|
Copyright©2008 PR Newswire.
All rights reserved